Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Discovery of novel pyrazole based Urea/Thiourea derivatives as multiple targeting VEGFR-2, EGFRWT, EGFRT790M tyrosine kinases and COX-2 Inhibitors, with anti-cancer and anti-inflammatory activities
Wael A.A. Fadaly, Mohamed T. M. Nemr, Nesma M. Kahk
Bioorganic Chemistry (2024) Vol. 147, pp. 107403-107403
Closed Access | Times Cited: 18

Showing 18 citing articles:

Design, synthesis, antineoplastic activity of new pyrazolo[3,4-d]pyrimidine derivatives as dual CDK2/GSK3β kinase inhibitors; molecular docking study, and ADME prediction
Mohamed T. M. Nemr, Ahmed Elshewy, Mohammed L. Ibrahim, et al.
Bioorganic Chemistry (2024) Vol. 150, pp. 107566-107566
Closed Access | Times Cited: 14
Design, synthesis and cytotoxic evaluation of new thieno[2,3-d]pyrimidine analogues as VEGFR-2/AKT dual inhibitors, apoptosis and autophagy inducers
Heba K. Abd El-Mawgoud, Asmaa M. AboulMagd, Mohamed T. M. Nemr, et al.
Bioorganic Chemistry (2024) Vol. 150, pp. 107622-107622
Closed Access | Times Cited: 13
Novel benzenesulfonamide derivatives as potential selective carbonic anhydrase IX, XII inhibitors with anti-proliferative activity: Design, synthesis and in silico studies
Wael A.A. Fadaly, Fatma El Zahraa Ammar Mohamed, Mohamed T. M. Nemr, et al.
Bioorganic Chemistry (2024) Vol. 153, pp. 107881-107881
Closed Access | Times Cited: 9
Synthesis, COX-2 inhibition, anti-inflammatory activity, molecular docking, and histopathological studies of new pyridazine derivatives
Sara Y. Ewieda, Rasha A. Hassan, Eman Ahmed, et al.
Bioorganic Chemistry (2024) Vol. 150, pp. 107623-107623
Closed Access | Times Cited: 7
Incorporation of human β-defensin-1 into immunoliposomes to facilitate targeted autophagy therapy of colon carcinoma
Ying Huang, Xin Wang, Jian Huang, et al.
World Journal of Clinical Oncology (2025) Vol. 16, Iss. 3
Closed Access
Optimization of pyrazole/1,2,4-triazole as dual EGFR/COX-2 inhibitors: Design, synthesis, anticancer potential, apoptosis induction and cell cycle analysis
Nesma M. Kahk, Fatma El Zahraa Ammar Mohamed, Marwa M. Abdelhakeem, et al.
European Journal of Medicinal Chemistry (2025), pp. 117340-117340
Closed Access
Nitrogen, Oxygen, and Sulphur Heterocycles as Potent Anti‐Inflammatory Agents: Insight Into the Synthetic Routes
Mariam Khadri, Uday Shashikumar, Pei‐Chien Tsai, et al.
ChemistrySelect (2025) Vol. 10, Iss. 9
Closed Access
New amidrazone analogs as multi-kinase inhibitors: in-silico and biological investigation as an anticancer agent
Almeqdad Y. Habashneh, Mahmoud A. Al-Sha’er, Sanaa K. Bardaweel
Medicinal Chemistry Research (2025)
Closed Access
Synthesis and evaluation of carmofur analogs as antiproliferative agents, inhibitors to the main protease (Mpro) of SARS-CoV-2, and membrane rupture-inducing agents
Tiffany Gu, Ailing Lu, Xina Wang, et al.
Discover Chemistry. (2025) Vol. 2, Iss. 1
Open Access
Insight Study For Repurposing Of Certain Anti‐Inflammatory Drugs Based On Aspirin and Salicylic Acid Scaffolds For The Treatment of Cancer as CDKs Inhibitors: Cheminformatics and Anticancer Studies
Mohnad Abdalla, Ahmed E. Elmasry, Mohamed T. M. Nemr, et al.
ChemistrySelect (2025) Vol. 10, Iss. 15
Closed Access
Semi-synthesis and biological activities of heterocyclic compounds containing camphor
Zeinab S. Hamza, Wael N. Hozzein, Khaled El‐Adl, et al.
RSC Advances (2025) Vol. 15, Iss. 17, pp. 13199-13213
Open Access
Design, synthesis and biological evaluation of thienopyridine derivatives as c-Met kinase inhibitors
Tianyu Xie, Wenbo Hu, Lin You, et al.
Molecular Diversity (2024)
Closed Access | Times Cited: 3
In vivo evaluation of novel synthetic pyrazolones as CDK9 inhibitors with enhanced pharmacokinetic properties
Ebtehal M. Husseiny, Hamada S. Abulkhair, Samiha A. El‐Sebaey, et al.
Future Medicinal Chemistry (2024), pp. 1-19
Closed Access | Times Cited: 3
An overview on pharmaceutical applications of phosphodiesterase enzyme 5 (PDE5) inhibitors
Mohamed T. M. Nemr, Mohamad Abdelaziz, Mohamed Teleb, et al.
Molecular Diversity (2024)
Open Access | Times Cited: 2
Discovery of novel 4-trifluoromethyl-2-anilinoquinoline derivatives as potential anti-cancer agents targeting SGK1
Guangcan Xu, Lanlan Li, Mengfan Lv, et al.
Molecular Diversity (2024)
Closed Access | Times Cited: 1
Synthesis, biological activities and mechanistic studies of C20-ketone pachysandra alkaloids as anti-hepatocellular carcinoma agents
Jinfeng Zhao, Jing Bai, Xiang Yu, et al.
Molecular Diversity (2024)
Closed Access | Times Cited: 1
Whole-volume histogram analysis of spectral-computed tomography iodine maps characterizes HER2 expression in gastric cancer
Weiling Zhang, Jing Sun, Rongfang Huang, et al.
World Journal of Gastroenterology (2024) Vol. 30, Iss. 38, pp. 4211-4220
Closed Access | Times Cited: 1
New chalcone incorporated structurally modified pyridine‐pyrimidine derivatives as anticancer agents: Their design, synthesis, and in‐vitro evaluation
Swarupa Ketha, Chithaluri Sudhakar, Shashikala Kethireddy, et al.
Chemistry & Biodiversity (2024) Vol. 21, Iss. 12
Closed Access
Discovery and optimization of 4-(imidazo[1,2-a]pyrimidin-3-yl)thiazol-2-amine derivatives as novel phosphodiesterase 4 inhibitors
Zongmin Wu, Furong Zhang, Zhexin Chen, et al.
Molecular Diversity (2024)
Closed Access
Page 1

Scroll to top